GEH200521 (18F) injection

· GE Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEH200521 (18F) injection, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers [Phase 1]

See pricing